drugIndia
Cart
Glucowin-MV 1 Tablet SR

Glucowin-MV 1 Tablet SR

Glimepiride (1mg) + Voglibose (0.2mg) + Metformin (500mg)

Airas Healthcare Pvt Ltd
Epilepsy
152.00190.0020% OFF
In Stock
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
drugIndia verified
Save 79%
Best Alternative100% Match

Glimison-VM 1 Tablet SR

Unison Pharmaceuticals Pvt Ltd

Voglibose 0.2mg
Glimison-VM 1 Tablet SR

Pack Size

1 units

Price

31.6020% off
Glimison-VM 1 Tablet SR is 100% same as Glucowin-MV 1 Tablet SR
Better ValueSame QualitySame Effectiveness

Save ₹120

that's 79% off!

composition
  1. Voglibose 0.2mg
  2. Glimepiride 1mg
  3. Metformin 500mg
Buy Now
152.0020% OFF
190.00

About This Medicine

Product description & overview

Glucowin-MV 1 Tablet SR: For Optimized Blood Sugar Management

Glucowin-MV 1 Tablet SR is a combination medication containing Glimepiride, Metformin, and Voglibose, formulated to help regulate blood sugar levels in individuals with type 2 diabetes.

* Glimepiride (1mg): This sulfonylurea acts by stimulating insulin release from the pancreas.
* Metformin (500mg): A biguanide that improves glucose uptake by cells and lowers gluconeogenesis (sugar production by the liver).
* Voglibose (0.2mg): An alpha-glucosidase inhibitor that slows down the breakdown of carbohydrates in the digestive system, preventing rapid blood sugar spikes after meals.

This combined dosage provides a comprehensive approach to managing glucose levels, aiming for improved glycemic control and reduced risk of complications associated with diabetes.

Note: Always consult with your healthcare professional before starting or changing any medications. This product is not intended to diagnose, treat, cure, or prevent any disease.

Active composition

Glimepiride 1 mg

+2 more active ingredients

About Glimepiride

Glimepiride is an oral hypoglycemic agent used to manage blood sugar levels in patients with type 2 diabetes mellitus. It works by stimulating the pancreas to release more insulin, thereby lowering blood glucose levels and preventing the symptoms associated with diabetes. Glimepiride is often prescribed alongside diet and exercise to enhance glycemic control and reduce the risk of diabetes-related complications, such as kidney damage and neuropathy. In summary, Glimepiride is an essential medication for controlling blood sugar levels in type 2 diabetes patients.

How It Works

Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.

Medicine Strength
1 mg

All Active Ingredients

Glimepiride1 mg
Voglibose0.2 mg
Metformin500 mg

Voglibose

Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.

Metformin

Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.

Dosage & How to Use

Dosage information not available. Please consult your doctor or pharmacist.

Safety Advice

Important precautions

Side Effect Occurrence

Based on clinical trials and patient reports.

Overall Tolerance

Most patients tolerate well

Only 2.3% reported effects

Common Side Effects

Headache8%
Nausea5%
Dizziness3%
Fatigue2%
Rash1%
Higher
Lower

Safety Advice

Alcohol

It is unsafe to consume alcohol with Glucowin-MV 1 Tablet SR.

High Risk

Pregnancy

Glucowin-MV 1 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Medical Advice

Driving

Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.

Exercise Caution

Liver

Glucowin-MV 1 Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Glucowin-MV 1 Tablet SR may be needed. Please consult your doctor. Glucowin-MV 1 Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.

Regular Checkup

Breastfeeding

Glucowin-MV 1 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Consult Doctor

Kidney

Glucowin-MV 1 Tablet SR is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Glucowin-MV 1 Tablet SR is, however, not recommended in patients with severe kidney disease.

Regular Checkup

Customer Reviews

0 reviews for Glucowin-MV 1 Tablet SR

Products matching your search